Its in Biological Technology

One of the Nation's Leading Analytical Testing Laboratories is Now Easier to Access -- Pace Analytical Launches New Web Site to Showcase Its Three Business Divisions

Pace Analytical Services, Inc. Is Pleased To Announce The Launch Of Its New And Improved Website. The New Site Provides Users With A Comprehensive Overview Of Pace Analytical And Incorporates A More User-Friendly Design Layout To Enhance Functionality And Navigation. The Site Also Offers An Expan...

Omnio Healer Selects Eden Biodesign for cGMP Production of its Candidate Wound Healing and Anti-Infection Treatments

UMEA, Sweden, August 6 /PRNewswire/ -- Omnio Healer AB, a pioneer company developing novel therapies for wound healing and anti-infection, today announced that it has entered into a partnership agreement with Eden Biodesign. Under the agreement Eden Biodesign will provide process development a...

Marinus Pharmaceuticals Adds Two Life Sciences Veterans to its Board of Directors

BRANFORD, Conn., July 29 /PRNewswire/ -- Marinus Pharmaceuticals, Inc. a developer of drugs to treat serious neurological and psychiatric disorders, today announced the appointment of George F. Horner III of Sofinnova Ventures and Harry T. Rein of Foundation Medical Partners to its Board...

Northwest Biotherapeutics Announces Plans to De-list From AIM and Consolidate its Stock Market Listing in U.S.

BETHESDA, Md., July 23 /PRNewswire-FirstCall/ -- Northwest Biotherapeutics, Inc. (OTC Bulletin Board: NWBO; AIM: NWBT and NWBS) today announces that it will seek shareholder approval for the Company to cancel its listing on the London Stock Exchange's AIM market ("AIM") (the "De-lis...

Sirnaomics Receives SBIR Grant from NIH/NCI for Its Multi-Targeted Lung Cancer siRNA Therapeutics

GAITHERSBURG, Md., July 22 /PRNewswire/ -- Sirnaomics, Inc. (www.sirnaomics.com) announced today that the company has received an SBIR (small business innovation research) grant from National Cancer Institute (NCI), National Institute of Health (NIH), for its novel siRNA therapeutics to treat...

Double Helix Strengthens its Strategic Pricing and Reimbursement Practice with Hire of Caryn Zieses

NEW YORK, July 20 /PRNewswire/ -- Double Helix Consulting US, a division of London-based Double Helix Development group, today announced the appointment of Caryn Zieses to the position of Senior Consultant. Zieses joins a multidisciplinary team of highly experienced strategic pricing, reimbu...

SynCo Bio Partners Increases its Capacities by Expanding its Quality Team

AMSTERDAM, July 20 /PRNewswire/ -- SynCo Bio Partners B.V., the GMP contract manufacturer of biological-based vaccines and therapeutics, today announced that it had significantly expanded the number of clinical and commercial biopharmaceutical batches it is capable of releasing annually, whils...

Encorium Group Completes Sale of its U.S. Business to Pierrel Research USA; Announces Management Changes

WAYNE, Pa., July 17 /PRNewswire-FirstCall/ -- Encorium Group, Inc. (Nasdaq: ENCO ), a full service multinational clinical research organization (CRO) that provides design, development, and management capabilities for clinical trials and patient registries to many of the world's leading ph...

NeoStem, Inc. Appoints Leading Chinese Medical Official to Its Advisory Board

NEW YORK, July 16 /PRNewswire-FirstCall/ -- NeoStem, Inc. (NYSE Amex: NBS ), which is pioneering the pre-disease collection, processing and long-term storage of adult stem cells for future medical need, announced today it has entered into an advisory consulting agreement with Dr....

Champions Biotechnology Partners with Do-Coop Technologies to Advance Its Novel Oncology Compound Into Biomerk Tumorgraft(TM) Testing

BALTIMORE, July 16 /PRNewswire-FirstCall/ -- Champions Biotechnology, Inc. (OTC Bulletin Board: CSBR), a company engaged in the development of advanced preclinical platforms and tumor specific data to enhance the value of oncology drugs, has established a collaboration with Do-C...

China Biologic Products Hosts its First Forum for Strategy and Development

TAIAN CITY, China, July 16 /PRNewswire-Asia-FirstCall/ -- China Biologic Products, Inc. (OTC Bulletin Board: CBPO) ("China Biologic" or the "Company"), one of the leading plasma-based pharmaceutical companies in the People's Republic of China ("PRC"), today announced that the Company hosted a ...

Covance to Sell Its Interactive Voice and Web Response Services and Enter Into a Multi-Year Marketing Agreement with Phase Forward

PRINCETON, N.J., July 15 /PRNewswire-FirstCall/ -- Covance Inc. (NYSE: CVD ) today announced it has signed an agreement to sell its Interactive Voice & Web Response Services (IVRS/IWRS) business to Phase Forward (Nasdaq: PFWD ). In addition, Covance and Phase Forward have agree...

University of Florida Shands Cancer Center Selects OnCore(r) to Support its Collaborative Research Goals

An institutional goal to develop collaborative partnerships with other research organizations was a key factor in the recent decision by the University of Florida Shands Cancer Center (UFSCC) to select OnCore(r) products in support of their clinical and translational research informatics needs. W...

Gerresheimer Holds its own in Difficult Environment

- Sales in the First Half of 2009 (Excluding Technical Plastics) at Prior Year Level - Growth in the Pharma Business - Sales Decline in the Cyclical Segments of Cosmetics and Laboratory Glassware In the first half of 2009, Gerresheimer AG achieved sales at the pr...

EMcision Announces 510(k) Clearance of the Habib EndoHPB, its Novel Bipolar RF Device for the Palliation of Biliary and Pancreatic Tumours

EMcision Ltd. today announced clearance for marketing by the United States Food and Drug Administration (K083292) of its Habib™ EndoHPB device for the palliation of biliary and pancreatic tumours. London (PRWEB) July 14, 2009 -- EMcision Ltd. today announced clear...

Boston Scientific Announces European Approval for Its LATITUDE(R) Patient Management System

NATICK, Mass., July 13 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX ) today announced CE Mark for its LATITUDE(R) Patient Management system. The LATITUDE system remotely monitors patients with implantable cardiac devices, gathering information on both the device and...

Harvest Technologies Announces Completion of Patient Enrollment in its 60 Patient Clinical Trial in India Using Autologous Adult Stem Cells to Treat Patients With Non-Reconstructable Critical Limb Ischemia

PLYMOUTH, Mass., July 9 /PRNewswire/ -- Harvest Technologies Corp. ( www.harvesttech.com ) announced today that the company sponsored 60-patient clinical trial conducted at Sri Ramachandra Medical Center in Chennai, India using the company's BMAC System to treat patients with non-reconstructable...

DOR BioPharma Announces Issuance of European Patent for its LPM(TM) Oral Drug Delivery Technology

PRINCETON, N.J., July 8 /PRNewswire-FirstCall/ -- DOR BioPharma, Inc. (OTC Bulletin Board: DORB) (DOR or the Company), a late-stage biopharmaceutical company, announced today that it has received a European patent which addresses its Lipid Polymer Micelle (LPM(TM)) technology for the improved oral...

AEterna Zentaris: New Data Published on its Ghrelin Antagonist Compound, AEZS-123 (JMV2959), Supports its Use in Alcohol Addiction

Data published in July 7, 2009 Issue of Proceedings of the National Academy of Sciences QUEBEC CITY, July 7 /PRNewswire-FirstCall/ - AEterna Zentaris Inc. (NASDAQ: AEZS ; TSX: AEZ), a global biopharmaceutical company focused on endocrine therapy and oncology, today announced publi...

Encorium Group Updates Expected Timeframe with Respect to the Sale of its U.S. Business

WAYNE, Pa., July 1 /PRNewswire-FirstCall/ -- Encorium Group, Inc. (Nasdaq: ENCO ) , a full service multinational contract research organization (CRO) that provides design, development, and management capabilities for clinical trials and patient registries to many of the world's leading pharmace...

PROLOR Biotech Awarded Two U.S. Patents for Its Longer-Acting Human Growth Hormone and Longer-Acting Erythropoietin

NES-ZIONA, Israel, June 30 /PRNewswire-FirstCall/ -- PROLOR Biotech, Inc. (OTC Bulletin Board: PBTH), formerly Modigene Inc., today announced that the U. S. Patent and Trademark Office (PTO) has issued two new patents for the company's long-acting CTP-enhanced human growth hormone (hGH-CTP) and hu...

RainEarth (RNER) Continues to Expand its Marketing Force in China

BEIJING, June 29 /PRNewswire-Asia/ -- RainEarth Inc. (OTC Bulletin Board: RNER; "the Company"), announced today that the Company's Chinese subsidiary, Beijing Rain and Earth Technology Development Corp. Ltd. ("China RainEarth") attended the Fourth session of Marketing Forum for Medicine and He...

Gyros Raises SEK 80 Million to Accelerate the Commercialization of its Gyrolab(R) Systems for the Cost-Efficient Development of Biopharmaceuticals

UPPSALA, Sweden, June 29 /PRNewswire/ -- - Financing Led by SLS Invest Will Fund Gyros to Profitability Gyros AB, the leading provider of automated micro-immunoassays for therapeutic protein development, announces that it has raised SEK 80 million (approximately euro 7.5 million)...

Clavis Pharma Raises NOK 129 Million (USD 20 Million) in a Private Placement to Fund Further Development of its Pipeline of Novel Anticancer Drug Candidates

OSLO, Norway, June 26 /PRNewswire-FirstCall/ -- Clavis Pharma ASA (OSE: CLAVIS) today announced that the Company has raised NOK 129 million (equivalent to USD 20 million) in gross proceeds through a private placement of 10,750,000 new shares, each with a par value of NOK 1.00 at a price of NOK...

MIT is pleased to announce that it has received a US$ 500,000 private placement from its Chinese partners

DENVER, CO, June 25 /PRNewswire-FirstCall/ - Medical International Technology Inc. (MDLH. PK) ( http://www.mitcanada.ca http://www.mitinvest.ca ), MIT is pleased to announce that it has received a US$ 500,000 private placement from its Chinese partners and a new order of 200 units. This privat...

Biovista Inc. Announces Positive Efficacy Results in a Pre-Clinical Trial of its BVA-601 Repositioned Drug for Epilepsy

CHARLOTTESVILLE, Virginia, June 23 /PRNewswire/ -- Biovista Inc. today announced that BVA-601, its small-molecule drug targeting epilepsy, has shown positive results in the Kainic acid murine model of temporal lobe epilepsy. BVA-601, an existing drug that Biovista repositioned in epilepsy, exh...

Trubion Pharmaceuticals Announces Extension of Research Period Under Its Wyeth Collaboration

SEATTLE, June 22 /PRNewswire-FirstCall/ -- Trubion Pharmaceuticals, Inc. (Nasdaq: TRBN ) today announced that Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE ), has exercised its option under the terms of its collaboration agreement with Trubion to extend the research period for an addit...

Shamir Optical Industry Ltd. Announces Availability of Its Annual Report on Form 20-F Through Its Website

KIBBUTZ SHAMIR, Israel, June 18 /PRNewswire-FirstCall/ -- Shamir Optical Industry Ltd. (Nasdaq: SHMR ) a leading provider of innovative products and technology to the ophthalmic lens market, announced today that its annual report on Form 20-F, containing audited consolidated financial statements...

Innocoll Announces Provisional Findings From Its Three Phase 2 Clinical Trials Investigating CollaRx(R) GENTAMICIN TOPICAL for the Treatment and Prevention of Diabetic Foot Infections

ASHBURN, Va., June 18 /PRNewswire/ -- Innocoll, Inc., a privately-held biopharmaceutical company, announced positive provisional findings from its three phase 2 clinical trials sponsored by its wholly owned subsidiary, Innocoll Technologies Ltd, to investigate CollaRx(R) GENTAMICIN TOPICAL for the...

Johnson & Johnson Announces Regulatory Clearance for Its Planned Acquisition of Cougar Biotechnology

NEW BRUNSWICK, N.J., June 17 /PRNewswire-FirstCall/ -- Johnson & Johnson (NYSE: JNJ ) today announced the U.S. Federal Trade Commission has granted early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act with respect to its previously announced planned ...

MedNet Solutions Unveils New Naming and Functionality for its Flagship EDC/eClinical Offering

MINNETONKA, Minn., June 17 /PRNewswire/ -- MedNet Solutions, a global life sciences technology solutions company specializing in clinical study management systems, today unveiled ENLIGHTEN(TM) as the new name for its industry-leading EDC/eClinical technology solution. The company also announced...

GeneThera Extends its Reach Overseas

Results from Pharma Finance 2009 ARVADA, Colo., June 16 /PRNewswire-FirstCall/ -- GeneThera, Inc. (OTC: GTHR.PK). GeneThera, as a service and responsibility to our shareholders, is addressing our recent events. GeneThera Inc. recently attended Pharma Finance 2009, a Biotechnology, Medic...

ERT to Showcase Its Clinical Trials Portfolio at DIA's 45th Annual Meeting at Booth #507

PHILADELPHIA, June 15 /PRNewswire/ -- ERT (Nasdaq: ERES ), a leading provider of centralized ECG and eClinical technology, ePRO, and other services to the biopharmaceutical, medical device, and related industries, announced today that it will be showcasing its portfolio of products an...

Nanopoint Applies CE Mark to Its cellTRAY(R) Imaging and Microfluidics Systems

HONOLULU, June 15 /PRNewswire/ -- Nanopoint Inc., an award-winning developer of Microfluidics and Live Cell Imaging products, today announced that effective immediately its cellTRAY Imaging System and cellTRAY Fluidics System are available to the European marketplace. Nanopoint's cellTRAY Imaging ...

Sigma-Aldrich Introduces New Services Network Complementing Its Life Sciences Product Portfolio

Customers can now conveniently access a collection of support services that can be used on a short or long term basis to accelerate their research ST. LOUIS, June 9 /PRNewswire-FirstCall/ -- Sigma-Aldrich (Nasdaq: SIAL ) today announced the launch of its new Services Network desig...

Senesco Technologies, Inc. Announces the Appointment of Dr. Harlan W. Waksal, M.D. as Chairman of the Board of Directors and the Addition of Mr. Warren J. Isabelle, CFA to its Board of Directors

NEW BRUNSWICK, N.J., June 9 /PRNewswire-FirstCall/ -- Senesco Technologies, Inc. ("Senesco" or the "Company") (NYSE Amex: SNT ) today announced the appointment, effective June 8, 2009, of its current Board member, Dr. Harlan Waksal, M.D., to serve as Chairman of the Board, succeeding Mr. Rudol...

Cell Therapeutics Amends and Restates Its 'Modified Dutch Auction' Tender Offer to a Fixed Price Tender Offer for Any and All of Its $118.9 Million Outstanding Convertible Notes

SEATTLE, June 2 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (the "Company" or "CTI") (Nasdaq and MTA: CTIC) today announced that it has amended and restated its "Modified Dutch Auction" tender offer to a fixed price tender offer for any and all of the approximately $118.9 million outstanding...

Optimer Pharmaceuticals Announces Lower Recurrence Rates for Fidaxomicin Versus Vancocin(R) in Subgroup Analyses from Its Phase 3 Study for the Treatment of CDI

SAN DIEGO, June 2 /PRNewswire-FirstCall/ -- Optimer Pharmaceuticals, Inc. (Nasdaq: OPTR ) announced that additional results from its North American Phase 3 clinical study of fidaxomicin in patients with Clostridium difficile infection (CDI) were presented today by clinical investigator, Mark A...

Peregrine Pharmaceuticals Presents Promising Data From Its Phase II Bavituximab Breast Cancer Trial at 2009 ASCO Annual Meeting

- Interim Primary Endpoint Data from Phase II Study Shows 71% Objective Tumor Response Rate in Evaluable Patients Receiving Bavituximab Plus Docetaxel - - Secondary Endpoint Evaluation Shows Promising 7.4 Month Median Progression Free Survival in Initial Study Cohort - ORLANDO, Fla. and ...

TorreyPines Therapeutics Announces its Board of Directors' Approval of Plan of Liquidation and Dissolution

LA JOLLA, Calif., May 29 /PRNewswire/ -- TorreyPines Therapeutics, Inc. (Nasdaq: TPTX ) today announced that its Board of Directors has determined, after consideration of potential strategic and financing alternatives, that it is in the best interests of the Company and its stockholders to liqui...